Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.177.89ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.89ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.89ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.89NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
M.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
M.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
M.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
M.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.333ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.333ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.333ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.333NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.429ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.429ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.429ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.429NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.463ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.463ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.463ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.463NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
U.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
U.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
U.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
U.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.373ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.373ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.373ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.373NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.80ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.80ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.80ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.80NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.433ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.433ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.433ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.433NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
C.36.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
C.36.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.36.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.36.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AN.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AN.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AN.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AN.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.28ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.28ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.28ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.28NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.221.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.221.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used